BioForce Nanosciences Ownership
BFNH Stock | USD 0.34 0.25 42.37% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
BioForce |
BioForce Pink Sheet Ownership Analysis
About 82.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. BioForce Nanosciences last dividend was issued on the 28th of February 2020. The entity had 1:5 split on the 28th of February 2020. BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for BioForce Nanosciences Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BioForce Nanosciences Holdings please contact the company at 757 306 6090 or go to https://www.bioforceeclipse.com.BioForce Nanosciences Outstanding Bonds
BioForce Nanosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioForce Nanosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioForce bonds can be classified according to their maturity, which is the date when BioForce Nanosciences Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
BIOGEN INC Corp BondUS09062XAG88 | View | |
BIOGEN INC Corp BondUS09062XAH61 | View |
Currently Active Assets on Macroaxis
NVDA | NVIDIA | |
CRESY | Cresud SACIF y | |
GOOG | Alphabet Inc Class C | |
FMC | FMC Corporation | |
XYF | X Financial Class |
Other Information on Investing in BioForce Pink Sheet
BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.